GENE ONLINE|News &
Opinion
Blog

Moderna
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
FDA Approves Both Moderna’s and Pfizer/BioNTech’s Omicron Bivalent Vaccines in One Day
2022-08-31
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
Moderna’s Lawsuit Against Pfizer/BioNTech: What Does This Mean for Their Vaccine’s future?
2022-08-26
Moderna Follows Pfizer With Their Own Omicron BA.4/BA.5 Application to the FDA
2022-08-24
European Commision Purchases an additional 15 million Moderna Bivalent COVID-19 Vaccines
2022-08-09
Moderna to Supply 66 Million COVID-19 Boosters to US
2022-07-29
Innovating Drug Delivery Systems with Moderna’s Bob Langer
2022-07-26
NIH Launches mRNA Nipah Virus Vaccine Trial With Moderna
2022-07-12
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
2022-05-23
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
Alnylam Challenges Moderna and Pfizer with Patent Infringement
2022-03-18
Moderna Unveils Three New mRNA Vaccine Programs
2022-02-21
1 2 3 4 5
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top